ArticleEClinicalMedicine2026

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.

Monica Milano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.